• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前全科医生管理与生活方式相关疾病的趋势:来自“心脏关爱网络”小组的报告。

Current trends in lifestyle-related disease management by general practitioners: a report from the "Heart Care Network" groups.

出版信息

J Atheroscler Thromb. 2009;16(6):799-806. doi: 10.5551/jat.2352. Epub 2009 Dec 22.

DOI:10.5551/jat.2352
PMID:20032578
Abstract

AIMS

In Japan, it is believed that guidelines for lifestyle-related disease are used in routine clinical practice, however, there are few reports on the actual rate of healthcare conducted in accordance with these guidelines by general practitioners and on their usefulness in preventing cardiovascular events. Therefore, the Heart Care Network (HCN) groups were organized mainly by general practitioners treating lifestyle diseases in 62 areas of Japan.

METHODS

The HCN has collected data on lifestyle diseases in high-risk patients in routine practices and investigated management conditions, guideline target achievement rates and medication. Additionally, the incidence of cardiovascular events was assessed.

RESULTS

We analyzed 14,064 cases. The lipid profile, blood pressure, glycemic control were significantly improved over the 3 years. The incidence of cardiovascular events were significantly reduced by the achievement of target LDL cholesterol, systolic blood pressure and hemoglobin A1c and even after adjustment for age, gender, history of myocardial infarction, the reduction of these lifestyle-related parameters remains significant.

CONCLUSION

These results revealed the current trends in the healthcare activities of general practitioners, the management conditions for lifestyle diseases in CHD high-risk patients and their effects on reducing cardiovascular events.

摘要

目的

在日本,人们普遍认为与生活方式相关疾病的指南被用于常规临床实践中,但关于全科医生实际遵循这些指南的医疗保健的比率以及它们在预防心血管事件中的有效性的报告较少。因此,主要由治疗生活方式疾病的全科医生在日本的 62 个地区组织了心脏保健网络 (HCN) 小组。

方法

HCN 收集了常规实践中高危患者的生活方式疾病数据,并调查了管理条件、指南目标达标率和药物治疗情况。此外,还评估了心血管事件的发生率。

结果

我们分析了 14064 例病例。血脂谱、血压、血糖控制在 3 年内得到显著改善。通过实现目标 LDL 胆固醇、收缩压和糖化血红蛋白达标,心血管事件的发生率显著降低,即使在调整年龄、性别、心肌梗死史后,这些与生活方式相关的参数的降低仍然具有显著意义。

结论

这些结果揭示了全科医生医疗保健活动的现状、冠心病高危患者生活方式疾病的管理情况及其在降低心血管事件中的作用。

相似文献

1
Current trends in lifestyle-related disease management by general practitioners: a report from the "Heart Care Network" groups.当前全科医生管理与生活方式相关疾病的趋势:来自“心脏关爱网络”小组的报告。
J Atheroscler Thromb. 2009;16(6):799-806. doi: 10.5551/jat.2352. Epub 2009 Dec 22.
2
Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.在高和极高心血管风险患者中使用调脂治疗和降低低密度脂蛋白胆固醇目标达标情况:来自德国的真实世界证据。
Atherosclerosis. 2018 Jan;268:99-107. doi: 10.1016/j.atherosclerosis.2017.11.020. Epub 2017 Nov 20.
3
Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland.瑞士日常实践中当前的心血管风险管理模式,特别关注降脂治疗。
Eur J Cardiovasc Prev Rehabil. 2010 Jun;17(3):363-72. doi: 10.1097/HJR.0b013e328333c1d9.
4
[Revision Dutch Guideline Cardiovascular Disease Prevention 2019].[2019年荷兰心血管疾病预防指南修订版]
Ned Tijdschr Geneeskd. 2019 Aug 29;163:D4237.
5
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.在管理式医疗环境中,以低高密度脂蛋白胆固醇为靶点降低残余心血管风险。
J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1.
6
National trends in the management of cardiovascular disease risk factors in children: second NHLBI survey of primary care physicians.儿童心血管疾病危险因素管理的全国趋势:美国国立心肺血液研究所对初级保健医生的第二次调查
Pediatrics. 1998 Nov;102(5):E50. doi: 10.1542/peds.102.5.e50.
7
Factors influencing general practitioners' decisions about cardiovascular disease risk reassessment: findings from experimental and interview studies.影响全科医生进行心血管疾病风险重新评估决策的因素:实验研究与访谈研究的结果
BMC Fam Pract. 2016 Aug 5;17:107. doi: 10.1186/s12875-016-0499-7.
8
Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.法国冠心病患者低密度脂蛋白胆固醇目标未达最佳水平。来自DYSIS II ACS/CHD研究的当代数据。
Arch Cardiovasc Dis. 2017 Mar;110(3):167-178. doi: 10.1016/j.acvd.2016.11.004. Epub 2017 Feb 13.
9
Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.在高或极高心血管风险患者中他汀类药物的应用和血脂目标达标情况:来自意大利普通实践的见解。
Atherosclerosis. 2018 Apr;271:120-127. doi: 10.1016/j.atherosclerosis.2018.02.024. Epub 2018 Feb 17.
10
Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan.现实世界中低密度脂蛋白胆固醇水平及调脂治疗处方模式:对日本33000多名心血管高危患者的分析
Atherosclerosis. 2016 Aug;251:248-254. doi: 10.1016/j.atherosclerosis.2016.07.001. Epub 2016 Jul 4.

引用本文的文献

1
Novel treatment approaches in hypertensive type 2 diabetic patients.高血压 2 型糖尿病患者的新型治疗方法。
World J Diabetes. 2014 Aug 15;5(4):536-45. doi: 10.4239/wjd.v5.i4.536.
2
Cardiovascular risk management with liaison critical path in Japan: its effects on implementation of evidence-based prevention in practice.日本通过联络关键路径进行心血管风险管理:其对循证预防措施在实际应用中的实施效果
J Clin Med Res. 2012 Apr;4(2):102-9. doi: 10.4021/jocmr845w. Epub 2012 Mar 23.
3
Antihypertensive efficacy of the losartan/hydrochlorothiazide combination and its effect on plasma B-type natriuretic peptide in hypertensive patients uncontrolled by angiotensin II type 1 receptor antagonist-based therapy: a multicentre prospective observational study.
氯沙坦/氢氯噻嗪复方制剂的降压疗效及其对血管紧张素Ⅱ 1 型受体拮抗剂治疗未控制的高血压患者血浆 B 型利钠肽的影响:一项多中心前瞻性观察研究。
Clin Drug Investig. 2012 Mar 1;32(3):171-8. doi: 10.2165/11597620-000000000-00000.